SIKALIAS · KNOWLEDGE IN PRACTICE
Cosmetic development in Greece
EIREN and Firmie illustrate the development approach of Sikalias Pharmaceutical Laboratories for cosmetic CDMO partnerships.
EIREN · Designing with fewer ingredients
Need: straightforward baby care with a clear purpose for each ingredient. Approach: a focused oil, balm and single-dose range, with raw-material and packaging suitability assessed together. Development work includes stability, microbiological safety, CPSR and claim assessment before release.
Explore the project ↗Firmie · Active-led formulation design
Need: serums with clearly stated concentrations and an understandable routine. Approach: FIRM 5 as the core product and NIGHT 0.1 as a subsequent, optional step. Requirements include active compatibility, stability, protective packaging, tolerability assessment and evidence for finished-product performance.
Explore the project ↗From your brief to a CDMO programme
EIREN and Firmie are being developed by Sikalias Pharmaceutical Laboratories. They are not yet available for sale and no launch date has been announced. Share the category, target market, packaging and expected volume. A feasibility review, agreed scope and commercial proposal define the next steps.
Discuss your project ↗